IP Library Granted Patent US 9,732,095
Granted Patent B2
US 9,732,095 · App. 15/111,000 · Granted Aug 15, 2017

Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

Inventors: Venkateshwar Rao Gummadi (Bangalore, IN); Susanta Samajdar (Bangalore, IN)
Assignee: Aurigene Discovery Technologies Limited
C07D513/04C07D498/04C07D519/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,732,095
App. No.
15/111,000
Granted
Aug 15, 2017
Kind
B2
Abstract

The present invention provides bicyclic heterocyclyl kinase enzyme inhibitor compounds of formula (I), which are therapeutically useful as kinase inhibitors, particularly IRAK4 inhibitors, wherein A, Y, Z, X 1 , X 2 , R 1 , R 3 , ‘m’, ‘n’ and ‘p’ have the meanings given in the specification and pharmaceutically acceptable salt or stereoisomer thereof that are useful in the treatment and prevention of diseases or disorder, in particular their use in diseases or disorder mediated by kinase enzyme, particularly IRAK4 enzyme. The present invention also provides pharmaceutical composition comprising at least one of the compounds of compound of formula (I) together with a pharmaceutically acceptable carrier, diluent or excipient therefor.

Claims (536)

1. A compound of formula (I):

or a pharmaceutically acceptable salt or a stereoisomer thereof;

wherein

X 1 and X 3 independently are CH or N; X 2 is CR 2 or N; provided one and not more than one of X 1 , X 2 or X 3 is N;

A is O or S;

Y is —CH 2 — or O;

Z is aryl or heterocyclyl;

R 1 , at each occurrence, is independently halo or optionally substituted heterocyclyl; wherein the substituent is alkyl, alkoxy, aminoalkyl, halo, hydroxyl, hydroxyalkyl or —NR a R b ;

R 2 is hydrogen, optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted heterocyclyl or —NR a R b ; wherein the substituent is alkyl, amino, halo or hydroxyl;

R 3 , at each occurrence, is alkyl or hydroxyl;

R a and R b are independently hydrogen, alkyl, acyl or heterocyclyl;

‘m’ and ‘n’ are independently 0, 1 or 2;

‘p’ is 0 or 1.

2. The compound of claim 1 , wherein

A is O or S;

Y is —CH 2 — or O;

Z is aryl or heterocyclyl;

R 1 , at each occurrence, is independently halo or optionally substituted heterocyclyl, wherein the substituent is alkyl, aminoalkyl, halo, or NR a R b ; where R a and R b are independently hydrogen, alkyl, or heterocyclyl;

R 2 is hydrogen, cycloalkyl, heterocyclyl or NR a R b ;

m is 0; and

n is 1.

3. The compound of claim 1 , wherein

A is O or S;

Y is —CH 2 — or O;

Z is aryl or heterocyclyl;

R 1 , at each occurrence, is independently halo or optionally substituted heterocyclyl; wherein the substituent is alkyl, alkoxy, aminoalkyl, halo, hydroxyl or NR a R b ; where R a and R b are independently hydrogen, alkyl, or heterocyclyl;

R 2 is hydrogen, cycloalkyl, optionally substituted heterocyclyl or NR a R b , where the substituent is selected from amino, halo or hydroxyl;

‘m’ and ‘n’ are independently 0, 1 or 2; and

‘p’ is 0 or 1.

4. The compound of claim 1 , or a pharmaceutically acceptable salt or a stereoisomer thereof, wherein the group

wherein R 2 is as defined in claim 1 .

5. The compound of claim 1 , wherein Z is aryl or 5- or 6-membered heterocyclyl.

6. The compound of claim 1 , wherein Z is an optionally substituted heterocyclyl selected from phenyl, furanyl, thienyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, 1H-tetrazolyl, oxadiazolyl, triazolyl, pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, azetidinyl, oxetanyl, imidazolidinyl, pyrrolidinyl, oxazolidinyl, thiazolidinyl, pyrazolidinyl, tetrahydrofuranyl, piperidinyl, piperazinyl, tetrahydropyranyl, morpholinyl, thiomorpholinyl, 1,4-dioxanyl, dioxidothiomorpholinyl, oxapiperazinyl, oxapiperidinyl, tetrahydrofuryl, tetrahydropyranyl, tetrahydrothiophenyl, dihydropyranyl or azabicyclo[3.2.1]octanyl; each of which is optionally substituted with alkyl, alkoxy, halo, hydroxyl, hydroxyalkyl or —NR a R b ; R a and R b are independently hydrogen, alkyl or acyl.

7. The compound of claim 1 represented by formula (IA):

or a pharmaceutically acceptable salt or a stereoisomer thereof;

wherein A, Y, R 1 , R 2 , R 3 , ‘m’, ‘p’ and ‘n’ are same as defined in claim 1 .

8. The compound of claim 7 , wherein

A is O or S;

Y is —CH 2 — or O;

R 1 , at each occurrence, is independently halo or optionally substituted heterocyclyl, wherein the substituent is alkyl, aminoalkyl, halo, or NR a R b ; where R a and R b are independently hydrogen, alkyl, or heterocyclyl;

R 2 is hydrogen, cycloalkyl, heterocyclyl or NR a R b ;

m is 0; and

n is 1.

9. The compound of claim 7 , wherein

A is O or S;

Y is —CH 2 — or O;

R 1 , at each occurrence, is independently halo or optionally substituted heterocyclyl; wherein the substituent is alkyl, alkoxy, aminoalkyl, halo, hydroxyl or NR a R b ; where R a and R b are independently hydrogen, alkyl, or heterocyclyl;

R 2 is hydrogen, cycloalkyl, optionally substituted heterocyclyl or NR a R b , where the substituent is selected from amino, halo or hydroxyl; and

‘m’ and ‘n’ are independently 0, 1 or 2.

10. The compound of claim 1 , represented by (TB):

or a pharmaceutically acceptable salt or a stereoisomer thereof;

wherein A, Y, R 1 , R 2 and ‘n’ are same as defined in claim 1 .

11. The compound of claim 10 , wherein

A is O or S;

Y is —CH 2 — or O;

R 1 , at each occurrence, is independently halo or optionally substituted heterocyclyl, wherein the substituent is alkyl, aminoalkyl, halo, or NR a R b ; where R a and R b are independently hydrogen, alkyl, or heterocyclyl;

R 2 is hydrogen, cycloalkyl, heterocyclyl or NR a R b ; and

n is 1.

12. The compound of claim 10 , wherein

A is O or S;

Y is —CH 2 — or O;

R 1 , at each occurrence, is independently halo or optionally substituted heterocyclyl; wherein the substituent is alkyl, alkoxy, aminoalkyl, halo, hydroxyl or NR a R b ; where R a and R b are independently hydrogen, alkyl, or heterocyclyl; and

R 2 is hydrogen, cycloalkyl, optionally substituted heterocyclyl or NR a R b , where the substituent is selected from amino, halo or hydroxyl.

13. The compound of formula (I) according to claim 1 , is a compound of formula (IC)

or a pharmaceutically acceptable salt or a stereoisomer thereof;

wherein A, Y, R 1 , R 2 and ‘n’ are same as defined in claim 1 .

14. The compound of claim 1 , wherein R 1 is optionally substituted heterocyclyl; wherein the substituent is alkyl, alkoxy, aminoalkyl, halo, hydroxyl, hydroxyalkyl or —NR a R b ; R a and R b are independently hydrogen or acyl.

15. The compound of claim 2 , wherein R 1 is optionally substituted heterocyclyl; wherein the substituent is alkyl, alkoxy, aminoalkyl, halo, hydroxyl, hydroxyalkyl or —NR a R b ; R a and R b are independently hydrogen or acyl.

16. The compound of claim 3 , wherein R 1 is optionally substituted heterocyclyl; wherein the substituent is alkyl, alkoxy, aminoalkyl, halo, hydroxyl, hydroxyalkyl or —NR a R b ; R a and R b are independently hydrogen or acyl.

17. The compound of claim 8 , wherein R 1 is optionally substituted heterocyclyl; wherein the substituent is alkyl, alkoxy, aminoalkyl, halo, hydroxyl, hydroxyalkyl or —NR a R b ; R a and R b are independently hydrogen or acyl.

18. The compound of claim 9 , wherein R 1 is optionally substituted heterocyclyl; wherein the substituent is alkyl, alkoxy, aminoalkyl, halo, hydroxyl, hydroxyalkyl or —NR a R b ; R a and R b are independently hydrogen or acyl.

19. The compound of claim 11 , wherein R 1 is optionally substituted heterocyclyl; wherein the substituent is alkyl, alkoxy, aminoalkyl, halo, hydroxyl, hydroxyalkyl or —NR a R b ; R a and R b are independently hydrogen or acyl.

20. The compound of claim 12 , wherein R 1 is optionally substituted heterocyclyl; wherein the substituent is alkyl, alkoxy, aminoalkyl, halo, hydroxyl, hydroxyalkyl or —NR a R b ; R a and R b are independently hydrogen or acyl.

21. The compound of claim 1 , wherein R 1 is optionally substituted heterocyclyl; and the substituent is alkyl, aminoalkyl, halo, or NR a R b ; where R a and R b are independently hydrogen, alkyl, or heterocyclyl.

22. The compound of claim 1 , wherein R 1 is optionally substituted heterocyclyl; and the substituent is alkyl, alkoxy, aminoalkyl, halo, hydroxyl or NR a R b ; where R a and R b are independently hydrogen, alkyl, or heterocyclyl.

23. The compound of claim 2 , wherein R 1 is optionally substituted heterocyclyl; and the substituent is alkyl, aminoalkyl, halo, or NR a R b ; where R a and R b are independently hydrogen, alkyl, or heterocyclyl.

24. The compound of claim 3 , wherein R 1 is optionally substituted heterocyclyl; and the substituent is alkyl, alkoxy, aminoalkyl, halo, hydroxyl or NR a R b ; where R a and R b are independently hydrogen, alkyl, or heterocyclyl.

25. The compound of claim 8 , wherein R 1 is optionally substituted heterocyclyl; and the substituent is alkyl, aminoalkyl, halo, or NR a R b ; where R a and R b are independently hydrogen, alkyl, or heterocyclyl.

26. The compound of claim 9 , wherein R 1 is optionally substituted heterocyclyl; and the substituent is alkyl, alkoxy, aminoalkyl, halo, hydroxyl or NR a R b ; where R a and R b are independently hydrogen, alkyl, or heterocyclyl.

27. The compound of claim 11 , wherein R 1 is optionally substituted heterocyclyl; and the substituent is alkyl, aminoalkyl, halo, or NR a R b ; where R a and R b are independently hydrogen, alkyl, or heterocyclyl.

28. The compound of claim 12 , wherein R 1 is optionally substituted heterocyclyl; and the substituent is alkyl, alkoxy, aminoalkyl, halo, hydroxyl or NR a R b ; where R a and R b are independently hydrogen, alkyl, or heterocyclyl.

29. The compound of claim 14 , wherein R 1 is pyridyl, pyrazolyl, pyrrolidinyl or piperidinyl.

30. The compound of claim 16 , wherein R 1 is optionally substituted pyrazolyl, wherein the substituent is alkyl, hydroxyl or —NR a R b .

31. The compound of claim 1 , wherein R 1 is halo.

32. The compound of claim 2 , wherein R 1 is halo.

33. The compound of claim 3 , wherein R 1 is halo.

34. The compound of claim 8 , wherein R 1 is halo.

35. The compound of claim 9 , wherein R 1 is halo.

36. The compound of claim 11 , wherein R 1 is halo.

37. The compound of claim 12 , wherein R 1 is halo.

38. The compound of claim 1 , wherein R 2 is hydrogen, cycloalkyl, heterocyclyl or NR a R b .

39. The compound of claim 1 , wherein R 2 is hydrogen, cycloalkyl, optionally substituted heterocyclyl or NR a R b , where the substituent is selected from amino, halo or hydroxyl.

40. The compound of claim 2 , wherein R 2 is hydrogen, cycloalkyl, heterocyclyl or NR a R b .

41. The compound of claim 3 , wherein R 2 is hydrogen, cycloalkyl, optionally substituted heterocyclyl or NR a R b , where the substituent is selected from amino, halo or hydroxyl.

42. The compound of claim 8 , wherein R 2 is hydrogen, cycloalkyl, heterocyclyl or NR a R b .

43. The compound of claim 9 , wherein R 2 is hydrogen, cycloalkyl, optionally substituted heterocyclyl or NR a R b , where the substituent is selected from amino, halo or hydroxyl.

44. The compound of claim 11 , wherein R 2 is hydrogen, cycloalkyl, heterocyclyl or NR a R b .

45. The compound of claim 12 , wherein R 2 is hydrogen, cycloalkyl, optionally substituted heterocyclyl or NR a R b , where the substituent is selected from amino, halo or hydroxyl.

46. The compound of claim 1 , wherein R 2 is optionally substituted heterocyclyl selected from piperidinyl, pyrrolidinyl, morpholinyl, piperazinyl, azetidinyl, pyrazolyl, furanyl or azabicyclo[3.2.1]octanyl; wherein the substituent is hydroxyl, halo, alkyl or amino.

47. The compound of claim 1 , wherein R 2 is piperidinyl, pyrrolidinyl, morpholinyl, or piperazinyl.

48. The compound of claim 3 , wherein R 2 is piperidinyl, pyrrolidinyl, morpholinyl, or piperazinyl.

49. The compound of claim 1 , wherein R 2 is hydrogen.

50. The compound of claim 2 , wherein R 2 is hydrogen.

51. The compound of claim 3 , wherein R 2 is hydrogen.

52. The compound of claim 42 , wherein R 2 is hydrogen.

53. The compound of claim 43 , wherein R 2 is hydrogen.

54. The compound of claim 44 , wherein R 2 is hydrogen.

55. The compound of claim 45 , wherein R 2 is hydrogen.

56. The compound of claim 1 , wherein R 2 is cycloalkyl.

57. The compound of claim 2 , wherein R 2 is cycloalkyl.

58. The compound of claim 3 , wherein R 2 is cycloalkyl.

59. The compound of claim 42 , wherein R 2 is cycloalkyl.

60. The compound of claim 43 , wherein R 2 is cycloalkyl.

61. The compound of claim 44 , wherein R 2 is cycloalkyl.

62. The compound of claim 45 , wherein R 2 is cycloalkyl.

63. The compound of claim 56 , wherein R 2 is cyclopropyl.

64. The compound of claim 1 , wherein R 3 is alkyl.

65. The compound of claim 3 , wherein R 3 is alkyl.

66. The compound of claim 9 , wherein R 3 is alkyl.

67. The compound of claim 12 , wherein R 3 is alkyl.

68. The compound of claim 1 , wherein m is O and p is 1.

69. The compound of claim 1 , wherein m is O or 2, and p is O or 1.

70. The compound of claim 2 , wherein m is O and p is 1.

71. The compound of claim 3 , wherein m is O or 2, and p is O or 1.

72. The compound of claim 8 , wherein m is O and p is 1.

73. The compound of claim 9 , wherein m is O or 2, and p is O or 1.

74. The compound of claim 11 , wherein m is O and p is 1.

75. The compound of claim 12 , wherein m is O or 2, and p is O or 1.

76. A compound is selected from:

Example No

IUPAC name

1.

6′-amino-N-(2-morpholinooxazolo[4,5-b]pyridin-6-yl)-[2,3′-bipyridine]-6-

carboxamide;

2.

6′-amino-N-(5-cyclopropyl-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-[2,3′-

bipyridine]-6-carboxamide hydrochloride;

3.

N-(5-cyclopropyl-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-4-

yl)oxazole-4-carboxamide hydrochloride;

4.

N-(2,5-di(piperidin-1-yl)oxazolo[4,5-b]pyridin-6-yl)-6-(1H-pyrazol-4-yl)picolinamide

hydrochloride;

5.

N-(2,5-di(piperidin-1-yl)oxazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-4-

yl)oxazole-4-carboxamide;

6.

N-(2-morpholino-5-(piperidin-1-yl)oxazolo[4,5-b]pyridin-6-yl)-6-(1H-pyrazol-4-

yl)picolinamide;

7.

2-(2-methylpyridin-4-yl)-N-(2-morpholino-5-(piperidin-1-yl)oxazolo[4,5-b]pyridin-6-

yl)oxazole-4-carboxamide;

8.

6-chloro-N-(2-morpholino-5-(piperidin-1-yl)oxazolo[4,5-b]pyridin-6-yl)picolinamide;

9.

N-(2,5-di(piperidin-1-yl)oxazolo[4,5-b]pyridin-6-yl)-6-(1-methyl-1H-pyrazol-4-

yl)picolinamide;

10.

2-(2-chloropyridin-4-yl)-N-(2,5-di(piperidin-1-yl)oxazolo[4,5-b]pyridin-6-yl)oxazole-

4-carboxamide;

11.

(S)-2-(2-methylpyridin-4-yl)-N-(2-morpholino-5-(pyrrolidin-3-ylamino)oxazolo[4,5-

b]pyridin-6-yl)oxazole-4-carboxamide;

12.

6′-amino-N-(2-morpholinooxazolo[5,4-b]pyridin-5-yl)-[2,3′-bipyridine]-6-

carboxamide;

13.

6′-amino-N-(2-morpholinothiazolo[4,5-c]pyridin-6-yl)-[2,3′-bipyridine]-6-

carboxamide;

14.

6′-amino-N-(2-morpholinothiazolo[5,4-b]pyridin-5-yl)-[2,3′-bipyridine]-6-

carboxamide;

15.

2-(2-methylpyridin-4-yl)-N-(2-morpholinothiazolo[4,5-b]pyridin-6-yl)oxazole-4-

carboxamide;

16.

6′-amino-N-(2-morpholinothiazolo[4,5-b]pyridin-6-yl)-[2,3′-bipyridine]-6-

carboxamide;

17.

N-(2-morpholinothiazolo[4,5-b]pyridin-6-yl)-6-(1H-pyrazol-4-yl)picolinamide;

18.

3-(4-(aminomethyl)piperidin-1-yl)-5-fluoro-N-(2-morpholinothiazolo[4,5-b]pyridin-

6-yl)benzamide;

19.

2-(4-(aminomethyl)piperidin-1-yl)-5-fluoro-N-(2-morpholinothiazolo[4,5-b]pyridin-

6-yl)benzamide;

20.

2-(2-methylpyridin-4-yl)-N-(2-morpholino-5-(piperidin-1-yl)thiazolo[4,5-b]pyridin-6-

yl)oxazole-4-carboxamide;

21.

N-(2-morpholino-5-(piperidin-1-yl)thiazolo[4,5-b]pyridin-6-yl)-6-(1H-pyrazol-4-

yl)picolinamide;

22.

N-(2,5-di(piperidin-1-yl)thiazolo[4,5-b]pyridin-6-yl)-6-(1H-pyrazol-4-

yl)picolinamide;

23.

N-(2,5-di(piperidin-1-yl)thiazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-4-

yl)oxazole-4-carboxamide;

24.

N-(2,5-dimorpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-4-yl)oxazole-4-

carboxamide;

25.

N-(5-(4-methylpiperazin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

26.

N-(2,5-di(piperidin-1-yl)oxazolo[4,5-b]pyridin-6-yl)-2-(6-methoxypyridin-3-

yl)oxazole-4-carboxamide;

27.

N-(2,5-di(piperidin-1-yl)oxazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-3-

yl)oxazole-4-carboxamide;

28.

N-(2,5-di(piperidin-1-yl)oxazolo[4,5-b]pyridin-6-yl)-2-(2-hydroxypyridin-3-

yl)oxazole-4-carboxamide;

29.

2-(2-hydroxypyridin-3-yl)-N-(2-morpholino-5-(piperidin-1-yl)oxazolo[4,5-b]pyridin-

6-yl)oxazole-4-carboxamide;

30.

N-(2,5-di(piperidin-1-yl)oxazolo[4,5-b]pyridin-6-yl)-2-(6-hydroxypyridin-3-

yl)oxazole-4-carboxamide;

31.

2-(2-methoxypyridin-4-yl)-N-(2-morpholino-5-(piperidin-1-yl)oxazolo[4,5-b]pyridin-

6-yl)oxazole-4-carboxamide;

32.

2-(2-methylpyridin-3-yl)-N-(2-morpholino-5-(piperidin-1-yl)oxazolo[4,5-b]pyridin-6-

yl)oxazole-4-carboxamide;

33.

2-(3-methylpyridin-4-yl)-N-(2-morpholino-5-(piperidin-1-yl)oxazolo[4,5-b]pyridin-6-

yl)oxazole-4-carboxamide;

34.

N-(2,5-di(piperidin-1-yl)oxazolo[4,5-b]pyridin-6-yl)-2-(3-methylpyridin-4-

yl)oxazole-4-carboxamide;

35.

2-(6-methylpyridin-3-yl)-N-(2-morpholino-5-(piperidin-1-yl)oxazolo[4,5-b]pyridin-6-

yl)oxazole-4-carboxamide;

36.

6-(1-methyl-1H-pyrazol-4-yl)-N-(2-morpholino-5-(piperidin-1-yl)oxazolo[4,5-

b]pyridin-6-yl)picolinamide;

37.

N-(2,5-di(piperidin-1-yl)oxazolo[4,5-b]pyridin-6-yl)-2-(6-methylpyridin-3-

yl)oxazole-4-carboxamide;

38.

(S)-N-(5-(3-aminopyrrolidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

39.

(S)-N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

40.

(R)-N-(5-(3-aminopyrrolidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

41.

(R)-N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

42.

(S)-2-(3-aminopyrrolidin-1-yl)-N-(2-morpholino-5-(piperidin-1-yl)oxazolo[4,5-

b]pyridin-6-yl)oxazole-4-carboxamide;

43.

(S)-6-(3-hydroxypyrrolidin-1-yl)-N-(2-morpholino-5-(piperidin-1-yl)oxazolo[4,5-

b]pyridin-6-yl)picolinamide;

44.

(S)-6-(3-aminopyrrolidin-1-yl)-N-(2-morpholino-5-(piperidin-1-yl)oxazolo[4,5-

b]pyridin-6-yl)picolinamide;

45.

(S)-2-(3-hydroxypyrrolidin-1-yl)-N-(2-morpholino-5-(piperidin-1-yl)oxazolo[4,5-

b]pyridin-6-yl)oxazole-4-carboxamide;

46.

(S)-N-(5-cyclopropyl-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(3-

hydroxypyrrolidin-1-yl)oxazole-4-carboxamide;

47.

(S)-2-(3-aminopyrrolidin-1-yl)-N-(5-cyclopropyl-2-morpholinooxazolo[4,5-b]pyridin-

6-yl)oxazole-4-carboxamide;

48.

2-(2-methylpyridin-4-yl)-N-(5-(piperidin-1-yl)-2-(pyrrolidin-1-yl)oxazolo[4,5-

b]pyridin-6-yl)oxazole-4-carboxamide hydrochloride;

49.

N-(2-(2,6-dimethylmorpholino)-5-(piperidin-1-yl)oxazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide hydrochloride;

50.

N-(2,5-di(piperidin-1-yl)thiazolo[4,5-b]pyridin-6-yl)-6-(1-methyl-1H-pyrazol-4-

yl)picolinamide hydrochloride;

51.

6-(1-methyl-1H-pyrazol-4-yl)-N-(2-morpholino-5-(piperidin-1-yl)thiazolo[4,5-

b]pyridin-6-yl)picolinamide;

52.

N-(2,5-di(piperidin-1-yl)thiazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-3-

yl)oxazole-4-carboxamide hydrochloride;

53.

N-(2-((2S,6R)-2,6-dimethylmorpholino)-5-(piperidin-1-yl)thiazolo[4,5-b]pyridin-6-

yl)-2-(2-methylpyridin-4-yl)oxazole-4-carboxamide;

54.

2-(2-methylpyridin-3-yl)-N-(2-morpholino-5-(piperidin-1-yl)thiazolo[4,5-b]pyridin-6-

yl)oxazole-4-carboxamide;

55.

2-(2-hydroxypyridin-3-yl)-N-(2-morpholino-5-(piperidin-1-yl)thiazolo[4,5-b]pyridin-

6-yl)oxazole-4-carboxamide;

56.

N-(2,5-di(piperidin-1-yl)thiazolo[4,5-b]pyridin-6-yl)-2-(2-methoxypyridin-4-

yl)oxazole-4-carboxamide;

57.

2-(6-methoxypyridin-3-yl)-N-(2-morpholino-5-(piperidin-1-yl)thiazolo[4,5-b]pyridin-

6-yl)oxazole-4-carboxamide;

58.

2-(2-methoxypyridin-4-yl)-N-(2-morpholino-5-(piperidin-1-yl)thiazolo[4,5-b]pyridin-

6-yl)oxazole-4-carboxamide;

59.

(S)-N-(5-(3-fluoropiperidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

60.

2-(6-methylpyridin-3-yl)-N-(2-morpholino-5-(piperidin-1-yl)thiazolo[4,5-b]pyridin-6-

yl)oxazole-4-carboxamide;

61.

2-(3-methylpyridin-4-yl)-N-(2-morpholino-5-(piperidin-1-yl)thiazolo[4,5-b]pyridin-6-

yl)oxazole-4-carboxamide;

62.

(S)-6-(3-aminopyrrolidin-1-yl)-N-(2-morpholino-5-(piperidin-1-yl)thiazolo[4,5-

b]pyridin-6-yl)picolinamide;

63.

(S)-6-(3-hydroxypyrrolidin-1-yl)-N-(2-morpholino-5-(piperidin-1-yl)thiazolo[4,5-

b]pyridin-6-yl)picolinamide;

64.

(S)-6-(3-aminopyrrolidin-1-yl)-N-(2,5-di(piperidin-1-yl)thiazolo[4,5-b]pyridin-6-

yl)picolinamide;

65.

(S)-N-(2,5-di(piperidin-1-yl)thiazolo[4,5-b]pyridin-6-yl)-6-(3-hydroxypyrrolidin-1-

yl)picolinamide;

66.

(S)-2-(3-aminopyrrolidin-1-yl)-N-(2-morpholino-5-(piperidin-1-yl)thiazolo[4,5-

b]pyridin-6-yl)oxazole-4-carboxamide;

67.

(S)-N-(5-(3-aminopyrrolidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

68.

(S)-2-(3-aminopyrrolidin-1-yl)-N-(5-cyclopropyl-2-morpholinothiazolo[4,5-

b]pyridin-6-yl)oxazole-4-carboxamide;

69.

N-(5-cyclopropyl-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-4-

yl)oxazole-4-carboxamide;

70.

(S)-2-(3-hydroxypyrrolidin-1-yl)-N-(2-morpholino-5-(piperidin-1-yl)thiazolo[4,5-

b]pyridin-6-yl)oxazole-4-carboxamide;

71.

(S)-N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

72.

(S)-N-(5-cyclopropyl-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-6-(3-

hydroxypyrrolidin-1-yl)picolinamide;

73.

(S)-N-(5-cyclopropyl-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(3-

hydroxypyrrolidin-1-yl)oxazole-4-carboxamide;

74.

(S)-N-(5-cyclopropyl-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-6-(1-(2-

hydroxypropyl)-1H-pyrazol-4-yl)picolinamide;

75.

(S)-N-(5-cyclopropyl-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(1-(2-

hydroxypropyl)-1H-pyrazol-4-yl)oxazole-4-carboxamide;

76.

N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(6-

methoxypyridin-3-yl)oxazole-4-carboxamide;

77.

(S)-N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(6-

methoxypyridin-3-yl)oxazole-4-carboxamide;

78.

(R)-N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(6-

methoxypyridin-3-yl)oxazole-4-carboxamide;

79.

(S)-N-(5-(azetidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-6-(3-

hydroxypyrrolidin-1-yl)picolinamide;

80.

N-(5-(3-hydroxyazetidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

81.

(S)-N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-5-(2-

methylpyridin-4-yl)thiophene-2-carboxamide;

82.

(S)-N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-5-(2-

methylpyridin-4-yl)furan-2-carboxamide;

83.

(S)-N-(5-(3-hydroxypiperidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

84.

N-(5-(4-hydroxypiperidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide

85.

(R)-N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

86.

N-(5-(4-hydroxypiperidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-5-(2-

methylpyridin-4-yl)furan-2-carboxamide;

87.

N-(5-(azetidin-1-yl)-2-(piperidin-1-yl)thiazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

88.

2-(2-methylpyridin-4-yl)-N-(2-(piperidin-1-yl)-5-(pyrrolidin-1-yl)thiazolo[4,5-

b]pyridin-6-yl)oxazole-4-carboxamide;

89.

2-(2-methylpyridin-4-yl)-N-(2-morpholino-5-(pyrrolidin-1-yl)thiazolo[4,5-b]pyridin-

6-yl)oxazole-4-carboxamide;

90.

5-(2-methylpyridin-4-yl)-N-(2-morpholino-5-(piperidin-1-yl)thiazolo[4,5-b]pyridin-6-

yl)furan-2-carboxamide;

91.

N-(5-(azepan-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-4-

yl)oxazole-4-carboxamide;

92.

2-(2-aminopyridin-4-yl)-N-(2-morpholino-5-(piperidin-1-yl)thiazolo[4,5-b]pyridin-6-

yl)oxazole-4-carboxamide hydrochloride;

93.

N-(5-(azetidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-4-

yl)oxazole-4-carboxamide;

94.

(R)-N-(5-(3-hydroxypiperidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

95.

(R)-N-(5-(3-hydroxypiperidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-5-(2-

methylpyridin-4-yl)furan-2-carboxamide;

96.

(S)-6-(1-(2-hydroxypropyl)-1H-pyrazol-4-yl)-N-(2-morpholino-5-(piperidin-1-

yl)thiazolo[4,5-b]pyridin-6-yl)picolinamide

97.

N-(5-(4-fluoropiperidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-5-(2-

methylpyridin-4-yl)furan-2-carboxamide

98.

N-(5-(4-fluoropiperidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide hydrochloride

99.

N-(5-(1-methyl-1H-pyrazol-4-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

100.

N-(5-(3-fluorophenyl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-

4-yl)oxazole-4-carboxamide;

101.

N-(5-(4-hydroxypiperidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-5-(2-

methylpyridin-4-yl)furan-2-carboxamide;

102.

N-(5-(3-fluoropiperidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-5-(2-

methylpyridin-4-yl)furan-2-carboxamide;

103.

(S)-N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(6-

methoxypyridin-3-yl)oxazole-4-carboxamide;

104.

N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

105.

(R)-N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(6-

methoxypyridin-3-yl)oxazole-4-carboxamide;

106.

N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(6-

methoxypyridin-3-yl)oxazole-4-carboxamide;

107.

(S)-N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-5-(2-

methylpyridin-4-yl)furan-2-carboxamide;

108.

(S)-N-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-5-(2-

methylpyridin-4-yl)thiophene-2-carboxamide;

109.

N-(5-(azetidin-1-yl)-2-(piperidin-1-yl)oxazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

110.

2-(2-methylpyridin-4-yl)-N-(2-(piperidin-1-yl)-5-(pyrrolidin-1-yl)oxazolo[4,5-

b]pyridin-6-yl)oxazole-4-carboxamide;

111.

5-(2-methylpyridin-4-yl)-N-(2-morpholino-5-(piperidin-1-yl)oxazolo[4,5-b]pyridin-6-

yl)furan-2-carboxamide;

112.

N-(5-(azetidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-4-

yl)oxazole-4-carboxamide;

113.

2-(2-methylpyridin-4-yl)-N-(2-morpholino-5-(pyrrolidin-1-yl)oxazolo[4,5-b]pyridin-

6-yl)oxazole-4-carboxamide;

114.

N-(5-(4-hydroxypiperidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-5-(2-

methylpyridin-4-yl)furan-2-carboxamide;

115.

(R)-N-(5-(3-hydroxypiperidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-5-(2-

methylpyridin-4-yl)furan-2-carboxamide;

116.

N-(5-(furan-3-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-4-

yl)oxazole-4-carboxamide;

117.

N-(5-(3-fluoropiperidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

118.

N-(5-(4-hydroxypiperidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

119.

N-(5-(4-fluoropiperidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

120.

(S)-N-(5-(3-aminopiperidin-1-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

121.

2-(2-methylpyridin-4-yl)-N-(2-morpholino-5-(1H-pyrazol-4-yl)thiazolo[4,5-

b]pyridin-6-yl)oxazole-4-carboxamide;

122.

N-(5-(6-fluoropyridin-3-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

123.

N-(5-(3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)-2-morpholinothiazolo[4,5-b]pyridin-

6-yl)-2-(2-methylpyridin-4-yl)oxazole-4-carboxamide;

124.

N-(2-(3-hydroxypiperidin-1-yl)-5-(piperidin-1-yl)thiazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

125.

2-(2-acetamidopyridin-4-yl)-N-(5-(4-hydroxypiperidin-1-yl)-2-

morpholinothiazolo[4,5-b]pyridin-6-yl)oxazole-4-carboxamide;

126.

N-(2-(3-hydroxypiperidin-1-yl)-5-(4-hydroxypiperidin-1-yl)thiazolo[4,5-b]pyridin-6-

yl)-2-(2-methylpyridin-4-yl)oxazole-4-carboxamide;

127.

2-(2-acetamidopyridin-4-yl)-N-(5-(3-hydroxypiperidin-1-yl)-2-

morpholinothiazolo[4,5-b]pyridin-6-yl)oxazole-4-carboxamide;

128.

2-(2-aminopyridin-4-yl)-N-(5-(3-hydroxypiperidin-1-yl)-2-morpholinothiazolo[4,5-

b]pyridin-6-yl)oxazole-4-carboxamide hydrochloride;

129.

5-(2-aminopyridin-4-yl)-N-(5-(4-hydroxypiperidin-1-yl)-2-morpholinothiazolo[4,5-

b]pyridin-6-yl)furan-3-carboxamide hydrochloride;

130.

2-(2-aminopyridin-4-yl)-N-(5-(4-hydroxypiperidin-1-yl)-2-morpholinothiazolo[4,5-

b]pyridin-6-yl)oxazole-4-carboxamide hydrochloride;

131.

2-(2-aminopyridin-4-yl)-N-(5-(4-fluoropiperidin-1-yl)-2-morpholinothiazolo[4,5-

b]pyridin-6-yl)oxazole-4-carboxamide hydrochloride;

132.

N-(5-(2-fluoropyridin-4-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide;

133.

N-(5-(4-fluoropiperidin-1-yl)-2-(3-hydroxypiperidin-1-yl)thiazolo[4,5-b]pyridin-6-

yl)-2-(2-methylpyridin-4-yl)oxazole-4-carboxamide;

134.

N-(5-(4-aminopiperidin-1-yl)-2-(3-hydroxypiperidin-1-yl)thiazolo[4,5-b]pyridin-6-

yl)-2-(2-methylpyridin-4-yl)oxazole-4-carboxamide hydrochloride; and

135.

N-(5-(2-hydroxypyridin-4-yl)-2-morpholinothiazolo[4,5-b]pyridin-6-yl)-2-(2-

methylpyridin-4-yl)oxazole-4-carboxamide hydrochloride;

or a pharmaceutically acceptable salt or a stereoisomer thereof.

77. A pharmaceutical composition comprising at least one compound according to claim 1 , or a pharmaceutically acceptable salt or a stereoisomer thereof, and a pharmaceutically acceptable carrier or excipient.

Assignments (3)
CHANGE OF NAME Recorded Mar 3, 2025
From: AURIGENE DISCOVERY TECHNOLOGIES LIMITED
To: AURIGENE ONCOLOGY LIMITED
Reel/Frame 070378/0823 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2016
From: GUMMADI, VENKATESHWAR RAO; SAMAJDAR, SUSANTA
To: AURIGENE DISCOVERY TECHNOLOGIES LIMITED
Reel/Frame 040689/0320 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2016
From: GUMMADI, VENKATESHWAR RAO; SAMAJDAR, SUSANTA
To: AURIGENE DISCOVERY TECHNOLOGIES LIMITED
Reel/Frame 040350/0479 →
Priority Claims (2)
IN 158/CHE/2014 · Jan 13, 2014 · national
IN 3000/CHE/2014 · Jun 20, 2014 · national
Continuity (1)
Related Publication 20160340366A1 · Nov 24, 2016